Cadrenal Therapeutics Inc (CVKD)
0.4905
+0.03
(+5.48%)
USD |
NASDAQ |
May 03, 16:00
0.4926
0.00 (0.00%)
After-Hours: 20:00
Cadrenal Therapeutics Cash from Operations (Quarterly): -0.6944M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.6944M |
| September 30, 2023 | -0.6278M |
| June 30, 2023 | -0.7953M |
| Date | Value |
|---|---|
| March 31, 2023 | -1.413M |
| March 31, 2022 | -0.0437M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.413M
Minimum
Mar 2023
-0.0437M
Maximum
Mar 2022
-0.7148M
Average
-0.6944M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Tenax Therapeutics Inc | -1.174M |
| Syra Health Corp | -1.757M |
| Minerva Neurosciences Inc | -5.991M |
| Adverum Biotechnologies Inc | -21.33M |
| Genprex Inc | -4.964M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.0125M |
| Free Cash Flow | -3.530M |
| Free Cash Flow Per Share (Quarterly) | -0.0433 |
| Free Cash Flow Yield | -53.38% |